Checklist for price notifications for pharmaceutical companies

  1. Check in the list published by Fimea that the information for the substitutable medicinal product is correct. Report any corrections and additions to Fimea within one week of the publication of the list.
  2. Check whether the product is subject to the price notification procedure in generic substitution and the reference price system. The list published by the Pharmaceuticals Pricing Board (Hila) includes all substitutable products as well as products undergoing a transition period.
  3. Submit a price notification for any product subject to the price notification procedure with Kela at the latest 21 days before the first day of each quarter. Kela forwards the notifications to Hila, which means that one price notification to Kela is sufficient. On the basis of the prices notified, Kela determines the price bands and Hila determines the reference prices. Kela forwards the prices, the price bands and the reference prices to the Pharmaceutical Database and the pharmacy price lists. The data take effect on the first day of the quarter.
  4. If the price of the product changes during the quarter, you must notify the new price to the Pharmaceutical Information Centre, the Association of Finnish Pharmacies and Yliopiston Apteekki in accordance with their instructions. Depending on the time of notification, the price is updated in the Pharmaceutical Database and on pharmacy price lists on the 1st or 15th of the month.

When a specific product is not subject to the price notification procedure in generic substitution and the reference price system

If the price of the product changes, you must notify the new price to the Pharmaceutical Information Centre, the Association of Finnish Pharmacies and Yliopiston Apteekki in accordance with their instructions. Depending on the time of notification, the price is updated in the Pharmaceutical Database and on pharmacy price lists on the 1st or 15th of the month.

Read more